Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4075-13-2

Post Buying Request

4075-13-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4075-13-2 Usage

Description

(8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one is a complex organic compound with a specific stereochemistry. It belongs to the class of androstanoids, which are derivatives of testosterone, a principal hormone of the testes. (8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one is characterized by the presence of a hydroxy group at the 17th position and two methyl groups at the 10th and 13th positions, along with a decahydrocyclopenta[a]phenanthren-3-one structure.

Uses

1. Used in Pharmaceutical Industry:
(8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one is used as a pharmaceutical compound for its potential therapeutic applications. (8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one's specific stereochemistry and structural features may contribute to its interaction with biological targets, making it a candidate for the development of new drugs.
2. Used in Research and Development:
(8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one can be utilized in research and development for understanding the structure-activity relationships of androstanoids and their derivatives. It may also be used to study the effects of stereochemistry on biological activity and to develop new methods for the synthesis of complex organic molecules.
3. Used in Metabolite Studies:
As a metabolite of testosterone, (8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one can be used in studies related to the metabolism of hormones, particularly in the context of endocrinology and reproductive health.
4. Used in Analytical Chemistry:
(8R,9S,10R,13S,14R,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one's unique structure and stereochemistry make it a valuable reference material for analytical chemistry, particularly in the development and validation of methods for the separation, identification, and quantification of complex organic molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 4075-13-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,7 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 4075-13:
(6*4)+(5*0)+(4*7)+(3*5)+(2*1)+(1*3)=72
72 % 10 = 2
So 4075-13-2 is a valid CAS Registry Number.
InChI:InChI=1/C19H26O3/c1-18-8-7-16-14(15(18)4-5-17(18)22)3-2-12-10-13(21)6-9-19(12,16)11-20/h10-11,14-17,22H,2-9H2,1H3/t14-,15-,16-,17-,18-,19+/m0/s1

4075-13-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (17α)-17-Hydroxyandrost-4-en-3-one

1.2 Other means of identification

Product number -
Other names 19-Aldotestosterone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4075-13-2 SDS

4075-13-2Upstream product

4075-13-2Downstream Products

4075-13-2Relevant articles and documents

Method of treating prostatic carcinoma

-

, (2008/06/13)

Compounds of the following general formula are useful in treating prostatic carcinoma: STR1 wherein R is --CHO or --CH2 OR1 ; each of R1 and R2 is hydrogen, alkylcarbonyl wherein the alkyl moiety has from 1 to 20 carbon atoms and is straight or branched, benzoyl, phenylalkylcarbonyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched or cycloalkylcarbonyl wherein the cycloalkyl moiety has from 5 to 10 carbon atoms; R3 is hydrogen; or R2 and R3 together form a double bond between the 17-position carbon atom and the oxygen atom.

METHOD OF INDUCING AN ESTROGENIC RESPONSE

-

, (2008/06/13)

Compounds of the following general formula are useful in inducing an estrogenic response in a patient in need thereof: STR1 wherein R is--CHO or--CH 2 OR 1 ; each of R 1 and R 2 is hydrogen, alkylcarbonyl wherein the alkyl moiety has from 1 to 20 carbon atoms and is straight or branched, benzoyl, phenylalkylcarbonyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched or cycloalkylcarbonyl wherein the cycloalkyl moiety has from 5 to 10 carbon atoms; R 3 is hydrogen; or R 2 and R 3 together form a double bond between the 17-position carbon atom and the oxygen atom.

Growth promotion

-

, (2008/06/13)

A method of promoting the growth of ruminants and poultry without concommitant adrogenizing effects using the following compound: STR1 wherein R is --CHO or --CH2 OR1 ; each of R1 and R2 is hydrogen, alkylcarbonyl wherein the alkyl moiety has from 1 to 20 carbon atoms and is straight or branched, benzoyl, phenylalkylcarbonyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched or cycloalkylcarbonyl wherein the cycloalkyl moiety has from 5 to 10 carbon atoms; R3 is hydrogen; or R2 and R3 together form a double bond between the 17- position carbon atom and the oxygen atom.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4075-13-2